Patients who achieved a pathologic complete response after neoadjuvant therapy had better survival outcomes than patients who received adjuvant therapy.

In the years since targeted treatments for CLL were introduced, their use in the second line has increased, but chemotherapy regimens remain the most common first-line treatment in these patients.

(HealthDay News) — Most Americans don’t plan to get vaccinated against the flu or COVID-19 this season, according to a survey from the National Foundation for Infectious Diseases (NFID).

The incidence of cardiovascular disease is higher in older adults with cancer, especially those with hematologic, lung, and metastatic cancers.